| Literature DB >> 28725708 |
Thibaut Neutelings1, Betty V Nusgens1, Yi Liu2, Sara Tavella2, Alessandra Ruggiu2, Ranieri Cancedda2, Maude Gabriel1, Alain Colige1, Charles Lambert1.
Abstract
AIMS: The Mice Drawer System (MDS) Tissue Sharing program was the longest rodent space mission ever performed. It provided 20 research teams with organs and tissues collected from mice having spent 3 months on the International Space Station (ISS). Our participation to this experiment aimed at investigating the impact of such prolonged exposure to extreme space conditions on mouse skin physiology.Entities:
Year: 2015 PMID: 28725708 PMCID: PMC5515501 DOI: 10.1038/npjmgrav.2015.2
Source DB: PubMed Journal: NPJ Microgravity ISSN: 2373-8065 Impact factor: 4.415
Figure 1Pair-wise Pearson’s correlation rates (r2) between individual transcripts levels analyzed by microarray in wild-type (WT) and transgenic (Tg) mice in ground (G) and space (S) groups.
Figure 2Skin histology. (a) Masson’s trichrome staining of a ground control mouse showing the different skin layers. (b) Hematoxylin & eosin staining of full thickness skin sections of the three mice of the ground and the space group (WT, Tg1 & Tg2); the arrow points to an enlarged hair follicle showing the melanin granules typical of growing hair in anagen phase; the right panel illustrates the number of growing hair follicles penetrating the hypodermis per unit length of epidermis in the ground and space group. (c) Mean thickness in micrometer of the dermis, hypodermis, and panniculus carnosus of the skin in the ground and space group. *P=0.05, Student’s t-test. Bar=200 μm.
Skin biochemical parameters
|
|
| |
|---|---|---|
| Hydration (%) | 58.4±3.4 | 58.5±2.9 |
| (μg per mg wet weight) | ||
| Total collagen | 293±55 | 300±54 |
| Newly synthesized procollagen soluble in 0.15 M NaCl | 2.2±0.3 | 3.0±0.6* |
| 1 M NaCl | 2.3±0.3 | 3.4±0.7** |
| Collagen soluble in 0.5 M HAc | 23.2±3.9 | 24.5±3.2 |
*P=0.05, **P=0.03, Student's t-test.
Genes involved in extracellular matrix homeostasis significantly modulated (fold change ⩾1.5, P⩽0.05) in space (S) versus ground (G) mice
|
|
|
| P |
|---|---|---|---|
|
| |||
| | Collagen, type I, alpha1 | 1.53 | 0.045 |
| | Elastin microfibril interfacer 2 | −2.55 | 0.029 |
| | Procollagen C-endopeptidase enhancer2 | −1.72 | 0.034 |
| | Procollagen-proline 4-hydroxylase | −1.59 | 0.010 |
|
| |||
| | Tenascin XB | −1.69 | 0.017 |
| | Cysteine rich protein 61 | 2.84 | 0.004 |
| | Connective tissue growth factor | 2.65 | 0.001 |
|
| |||
| | Hyaluronan synthase 2 | −1.85 | 0.031 |
|
| |||
| | Collagen, type IV, alpha 4 | −1.72 | 0.040 |
| | Collagen, type VII, alpha 1 | 1.73 | 0.010 |
| | Laminin, alpha 2 | −1.68 | 0.034 |
|
| |||
| | A disintegrin-like and metallopeptidase with thrombospondin type 1 motif, 1 | 1.57 | 0.002 |
| | A disintegrin-like and metallopeptidase with thrombospondin type 1 motif, 9 | 1.69 | 0.035 |
| | Plasminogen activator, urokinase | −2.19 | 0.002 |
| | Serine peptidase inhibitor, clade E, member 1 | 3.96 | 0.010 |
|
| |||
| | Integrin alpha 1 | −2.08 | 0.024 |
| | Integrin beta 1 | 2.07 | 0.005 |
| | Integrin beta 1 binding protein 2 | 2.57 | 0.000 |
| | Integrin beta 2 | −2.03 | 0.047 |
| | Discoidin domain receptor, member 2 | −1.50 | 0.026 |
Student’s t-test.
Expression of hair follicles and interfollicular epidermal keratins
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| |||||||
| | Keratin 25 | 30322 | 33324 | 19052 | 37 | 54017 | 8177 |
| | Keratin 26 | 2918 | 6404 | 2187 | 70 | 12812 | 524 |
| | Keratin 27 | 15939 | 26423 | 9608 | 7 | 41441 | 3521 |
| | Keratin 28 | 481 | 854 | 229 | 46 | 1741 | 200 |
| | Keratin 34 | 7177 | 15010 | 7473 | 30 | 30606 | 1162 |
| | Keratin 35 | 4450 | 3389 | 2233 | 7 | 7172 | 1197 |
| | Keratin 71 | 6141 | 7584 | 4058 | 31 | 15802 | 1435 |
| | Keratin 72 | 2967 | 6535 | 1820 | 103 | 14306 | 607 |
| | Keratin 73 | 5845 | 7741 | 3476 | 49 | 17588 | 1876 |
| | Keratin 75 | 3659 | 4066 | 2882 | 1181 | 6438 | 746 |
| | Keratin 81 | 5824 | 10525 | 5432 | 165 | 21426 | 1248 |
| | Keratin 85 | 6156 | 6109 | 3377 | 80 | 15270 | 1217 |
| | Keratin 86 | 4308 | 9611 | 4342 | 5 | 20312 | 614 |
|
| |||||||
| | Keratin 1 | 7965 | 10103 | 8234 | 7135 | 4964 | 4866 |
| | Keratin 5 | 12547 | 12938 | 10587 | 16372 | 12781 | 10096 |
| | Keratin 6A | 6579 | 11621 | 8041 | 6510 | 12866 | 4035 |
| | Keratin 10 | 50853 | 49514 | 49304 | 53390 | 39709 | 45046 |
| | Keratin 14 | 12435 | 13312 | 10087 | 15079 | 15938 | 14753 |
| | Keratin 15 | 27353 | 28871 | 30512 | 37239 | 23270 | 20753 |
| | Keratin 17 | 135 | 124 | 135 | 106 | 135 | 70 |
| | Keratin 23 | 5231 | 5238 | 5340 | 4221 | 4357 | 3203 |
| | Keratin 77 | 32941 | 31471 | 34046 | 35237 | 26529 | 30776 |
| | Keratin 78 | 1273 | 1050 | 1333 | 1236 | 659 | 907 |
| | Keratin 79 | 8630 | 6897 | 6880 | 7511 | 3591 | 7508 |
| | Keratin 80 | 7576 | 7254 | 7754 | 7735 | 6785 | 4424 |
Abbreviations: Tg, transgenic; WT, wild type.
Genes with recognized function in muscle atrophy, differentiation, or contraction and significantly regulated in space versus ground groups
|
|
|
| P |
|---|---|---|---|
|
| |||
| | Actin binding rho-activating protein | 3.14 | 0.0046 |
| | Actinin alpha 2 | 3.01 | 0.0066 |
| | Ankyrin repeat domain 23 | 3.10 | 0.0043 |
| | Cysteine and glycine-rich protein 3 | 2.08 | 0.015 |
| | Desmin | 2.06 | 0.0063 |
| | Filamin, beta | 2.38 | 0.015 |
| | Filamin c, gamma | 3.12 | 0.035 |
| | Lim domain binding 3 | 2.42 | 0.00081 |
| | Leiomodin 2 (cardiac) | 3.35 | 0.014 |
| | Myosin-binding protein C, slow type | 2.23 | 0.0097 |
| | Myosin-binding protein C, fast type | 2.23 | 0.019 |
| | Myosin, heavy polypeptide 2, skeletal muscle, adult | 2.46 | 0.03 |
| | Myosin, light polypeptide kinase 2, skeletal muscle | 17.51 | 0.00003 |
| | Myomesin 1 | 2.42 | 0.0064 |
| | Myomesin 2 | 3.40 | 0.0042 |
| | Myomesin, family member 3 | 2.15 | 0.027 |
| | Myotilin | 2.50 | 0.002 |
| | Myozenin 2 | 2.78 | 0.008 |
| | Myozenin 3 | 2.20 | 0.0076 |
| | Nebulin | 2.48 | 0.0065 |
| | Nexilin | 2.65 | 0.0021 |
| | Nebulin-related anchoring protein | 2.38 | 0.012 |
| | Obscurin, cytoskeletal calmodulin, and titin-interacting rhogef | 2.99 | 0.0071 |
| | PDZ and LIM domain 3 | 3.71 | 0.00018 |
| | PDZ and LIM domain 7 | 2.15 | 0.015 |
| | Sarcoglycan, gamma (dystrophin-associated glycoprotein) | 2.00 | 0.011 |
| | Smoothelin-like 1 (localization?) | 2.26 | 0.027 |
| | SET and MYND domain containing 1 | 2.38 | 0.02 |
| | Synemin, intermediate filament protein | 2.80 | 0.00023 |
| | Synaptopodin 2 | 2.57 | 0.0035 |
| | Synaptopodin 2 like | 2.56 | 0.0025 |
| | Titin-cap | 2.07 | 0.0045 |
| | Tropomodulin 1 | 2.26 | 0.0041 |
| | Tropomodulin 4 | 2.37 | 0.0003 |
| | Troponin 1, skeletal, fast | 2.14 | 0.012 |
| | Tropomyosin 2, beta | 2.03 | 0.0026 |
| | Tripartite motif-containing 54 | 2.46 | 0.0017 |
| | Titin | 2.04 | 0.018 |
| | Xin actin-binding repeat containing 1 | 2.87 | 0.042 |
|
| |||
| | Ankyrin 1, erythroid | 2.03 | 0.0022 |
| | Atpase, Ca++ transporting, cardiac muscle, fast twitch 1 | 2.06 | 0.016 |
| | Calcium channel, voltage-dependent, L type, alpha 1S subunit | 2.56 | 0.0019 |
| | Calcium/calmodulin-dependent protein kinase II delta | 2.22 | 0.0074 |
| | Calsequestrin 1 | 2.50 | 0.011 |
| | Caveolin 3 | 2.26 | 0.0067 |
| | histidine-rich calcium binding protein | 2.06 | 0.03 |
| | Integrin beta 1-binding protein 2 | 2.57 | 0.00067 |
| | Junctophilin 2 | 2.30 | 0.03 |
| | Junctional sarcoplasmic reticulum protein 1 | 2.70 | 0.0019 |
| | Protein kinase C and casein kinase substrate in neurons 3 | 2.37 | 0.00002 |
| | Ryanodin receptor 1, skeletal muscle | 2.42 | 0.011 |
| | Solute carrier family 8 (sodium/calcium exchanger), member 3 | 2.24 | 0.012 |
| | Synaptophysin-like 2 | 2.01 | 0.0071 |
| | Triadin | 2.25 | 0.003 |
|
| |||
| | Amylo-1,6-glucosidase, 4-alpha-glucanotransferase | 2.11 | 0.0057 |
| | Creatine kinase, mitochondrial 2 (sarcomeric) | 3.30 | 0.0002 |
| | Cytochrome | 2.13 | 0.0077 |
| | Enolase 3, beta muscle | 2.49 | 0.0014 |
| | Myoglobin | 3.16 | 0.00016 |
| | Phosphofructokinase, muscle | 2.52 | 0.0026 |
| | Phosphoglycerate mutase 2 | 2.94 | 0.0012 |
| | Phosphorylase kinase alpha 1 | 2.02 | 0.0038 |
| | Phosphorylase kinase gamma 1 | 2.72 | 0.013 |
| | Protein phosphatase 1, regulatory (inhibitor) subunit 3C | 2.34 | 0.009 |
| | Muscle glycogen phosphorylase | 2.71 | 0.0049 |
| | Thioredoxin interacting protein | 2.07 | 0.023 |
|
| |||
| | Actin-binding Rho-activating protein | 3.14 | 0.0091 |
| | Alpha-kinase 3 | 2.2 | 0.0039 |
| | Ankyrin repeat and SOCS box containing 2 | 3.58 | 0.0015 |
| | Activating transcription factor 3 | 2.00 | 0.0063 |
| | Calpain 3 | 2.03 | 0.0019 |
| | Cysteine and glycine-rich protein 3 | 2.08 | 0.015 |
| | Doublesex and MAB3-related transcription factor 2 | −2.49 | 0.0027 |
| | F-box protein 32 | 2.13 | 0.046 |
| | Heat shock 27 kDa protein family, member 7 (cardiovascular) | 3.73 | 0.0052 |
| | Kelch repeat and BTB (POZ) domain containing 10 | 3.39 | 0.00063 |
| | Ladybird homeobox 1 | 2.73 | 0.0005 |
| | Myocyte enhancer factor 2C | 2.11 | 0.0015 |
| | Muscle-related coiled-coil protein | 2.29 | 0.034 |
| | Myogenic factor 6 | 2.22 | 0.0047 |
| | Myogenin | 2.13 | 0.026 |
| | PDZ and LIM domain 3 | 3.71 | 0.00018 |
| | PDZ and LIM domain 7 | 2.15 | 0.015 |
| | RNA binding motif 24 | 3.05 | 0.0011 |
| | Plasminogen activator inhibitor 1, PAI 1 | 3.96 | 0.00989 |
| | SET and MYND domain containing 1 | 2.38 | 0.02 |
| | Tripartite motif-containing 63 | 4.98 | 0.016 |
| | Vestigial like 2 (drosophila) | 2.23 | 0.028 |
Genes recognized as transcriptional targets or having a recognized or potential binding site for
MEF2 and/or
myogenin on their promoter.
Enriched systems in the skin of space mice
| P | |
|---|---|
|
| |
| Structural constituent of muscle | 1.31E−14 |
| Titin binding | 2.31E−07 |
| Cytoskeletal binding | 2.32E−07 |
| Actin binding | 1.52E−05 |
| Actinin binding | 2.08E−04 |
|
| |
| Muscle system process | 3.73E−18 |
| Muscle contraction | 2.63E−16 |
| Striated muscle contraction | 6.13E−11 |
| Muscle structure development | 2.83E−09 |
| Muscle tissue development | 7.37E−09 |
|
| |
| Myofibril | 5.07E−33 |
| Contractile fiber | 8.10E−33 |
| Sarcomere | 1.12E−32 |
| I band | 9.52E−24 |
|
| |
| Abnormal muscle contractility | 2.71E−06 |
| Impaired skeletal contractility | 3.09E−05 |
| Impaired muscle contractility | 3.32E−05 |
| Abnormal skeletal muscle morphology | 1.05E−04 |
| Abnormal muscle physiology | 1.10E−04 |
|
| |
| Striated muscle contraction | 7.38E−07 |
| Genes involved in striated muscle contraction | 9.19E−07 |
| Genes involved in muscle contraction | 3.02E−05 |
| Diurnally regulated genes with circadian orthologs | 1.46E−03 |
| Genes involved in glycogen breakdown | 4.71E−03 |
|
| |
| Titin (TTN) | 6.05E−09 |
| Titin-cap (TCAP) | 1.82E−03 |
| Nebulin (NEB) | 3.29E−03 |
| Myozenin 3 (MYOZ3) | 4.03E−03 |
| Tripartite motif-containing 63 (TRIM63) | 7.51E−03 |